Published in Gastroenterology on July 01, 1972
Mitochondrial antibodies (AMA). Gut (1974) 1.60
Autonomic dysfunction and cholelithiasis in patients with cirrhosis. Dig Dis Sci (2001) 1.43
The present position concerning gallstone dissolution. Gut (1974) 1.41
Natural history of cholelithiasis in patients with alcoholic cirrhosis (cholelithiasis in cirrhotic patients). Ann Surg (1987) 1.19
Laparoscopic cholecystectomy in cirrhotics. JSLS (2013) 1.09
Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg (1985) 0.99
Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy? Ann Surg (1993) 0.90
Development of black gallstones after the nonsurgical management of splenic injury: report of a case. Surg Today (1997) 0.83
Delayed laparoscopic cholecystectomy is safe and effective for acute severe calculous cholecystitis in patients with advanced cirrhosis: a single center experience. Gastroenterol Res Pract (2014) 0.83
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects. World J Gastroenterol (2014) 0.82
Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones. Dig Dis Sci (2004) 0.82
Laparoscopic cholecystectomy in cirrhotic patients. JSLS (2010) 0.80
Outcome of biliary tract surgery in unknown cirrhotics: a case-control study. Ann R Coll Surg Engl (1993) 0.80
Surgical treatment of hepatic adenoma and focal nodular hyperplasia. Gastroenterology (1978) 0.78
Ultrasonographic assessment of the gallbladder in 21 children with portal vein thrombosis. Pediatr Radiol (2004) 0.78
Color Doppler ultrasound detection and classification of the tangential hepatic vein before laparoscopic cholecystectomy. Surg Endosc (2005) 0.78
Biliary lipid secretion in chronic cholestatic liver disease. Gut (1982) 0.78
Bile acid clearance in liver disease. Gut (1979) 0.77
Gallstone composition. Br Med J (1973) 0.75
Liver disease in the alcoholic. Can Fam Physician (1986) 0.75
Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int (2017) 0.75
Alcohol protects against cholesterol gallstone formation. Ann Surg (1988) 0.75
Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China. Medicine (Baltimore) (2017) 0.75
The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials (1985) 6.22
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58
Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med (1976) 3.19
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Liver disease associated with secondary syphilis. N Engl J Med (1971) 2.51
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) (1971) 2.26
Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis (1977) 2.15
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology (1977) 2.10
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology (1989) 2.05
Prophylactic portacaval anastomosis. Medicine (Baltimore) (1972) 1.99
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Cryptococcal skeletal infections: case report and review. Rev Infect Dis (1990) 1.80
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother (1972) 1.64
A rational approach to the hepatorenal syndrome. Gastroenterology (1973) 1.63
Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology (1979) 1.52
Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology (1974) 1.50
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47
'Normal' CSF in bacterial meningitis. JAMA (1980) 1.46
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med (1967) 1.43
Autism and the X chromosome. Multipoint sib-pair analysis. Arch Gen Psychiatry (1996) 1.42
Transjugular intrahepatic portosystemic shunts versus sclerotherapy: a discussion of discordant results. Ann Intern Med (1997) 1.40
Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency. N Engl J Med (1973) 1.37
Genetics of autism: characteristics of affected and unaffected children from 37 multiplex families. Am J Med Genet (1994) 1.35
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med (1969) 1.35
A peek at the Child-Turcotte classification. Hepatology (1982) 1.34
Esophageal tamponade in the treatment of bleeding varices. A decadel progress report. Dig Dis Sci (1980) 1.34
Pharmacology of cefazolin in human volunteers. J Clin Pharmacol (1973) 1.29
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med (1974) 1.29
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am (1975) 1.27
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Selective intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage. Gastroenterology (1972) 1.23
Ideal treatment of portal hypertension in 1985. Clin Gastroenterol (1985) 1.21
Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology (1974) 1.16
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Erythromycin: clinical review I. Clinical pharmacology. N Y State J Med (1977) 1.14
A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis (1998) 1.12
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology (2001) 1.09
Short-term effects of propranolol on portal venous pressure. Hepatology (1986) 1.08
The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med (1974) 1.08
Percutaneous versus peritoneoscopic liver biopsy. Gastroenterology (1972) 1.07
Absence of linkage and linkage disequilibrium to chromosome 15q11-q13 markers in 139 multiplex families with autism. Am J Med Genet (1999) 1.06
Analysis of ascitic fluid in cirrhosis. Dig Dis Sci (1979) 1.04
Endoscopic sclerotherapy: an analysis of variants. Hepatology (1983) 1.03
A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology (1979) 1.02
Tyrosine metabolism in patients with liver disease. J Clin Invest (1967) 1.02
Is hepatic scanning overated? Gastroenterology (1968) 1.01
Spontaneous meningococcal peritonitis: a report of two cases. Am J Dig Dis (1978) 1.00
Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis (1985) 1.00
Comparison of the histologic and cytologic diagnosis of liver biopsies in hepatic cancer. Gastroenterology (1979) 1.00
Concentration of clindamycin in human bone. Antimicrob Agents Chemother (1975) 0.99
Hepatic injury caused by L-alpha-methyldopa. Circulation (1969) 0.99
Excessive mortality associated with balloon tamponade of bleeding varices. A critical reappraisal. JAMA (1967) 0.99
Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis. Am J Dig Dis (1971) 0.98
Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. Gastroenterology (1977) 0.97
Liver biopsy in extrahepatic biliary obstruction and in other "contraindicated" disorders. Gastroenterology (1975) 0.97
A statistical analysis of reviewer agreement and bias in evaluating medical abstracts. Yale J Biol Med (1976) 0.97
The diagnosis of bacterial peritonitis: comparison of pH, lactate concentration and leukocyte count. Hepatology (1985) 0.96
Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. Am J Dig Dis (1977) 0.95
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery (2001) 0.95
Cephalexin: pharmacologic evaluation following oral and parenteral administration. J Clin Pharmacol (1973) 0.95
The syndrome of immunoglobulin deficiency and pernicious anemia. A study of ten cases. Am J Med (1969) 0.94
Spontaneous bacterial peritonitis. Multiple revisitations. Gastroenterology (1976) 0.94
Pernicious anemia and immunologic deficiency. Ann Intern Med (1968) 0.94
Sengstaken-Blakemore tube revisited. Gastroenterology (1971) 0.94
Molecular analysis and test of linkage between the FMR-1 gene and infantile autism in multiplex families. Am J Hum Genet (1994) 0.94
To scope or not to scope. N Engl J Med (1981) 0.93
Portacaval anastomosis and hepatic hemosiderin deposition: a prospective, controlled investigation. Gastroenterology (1972) 0.93
Intrahepatic hematoma after liver biopsy. Gastroenterology (1974) 0.93
The varix volcano connection. Gastroenterology (1980) 0.92
Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon. Gastroenterology (1978) 0.92
Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology (1986) 0.91
Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology (1984) 0.91
Disturbance of the jejunal and colonic bacterial flora in immunoglobulin deficiencies. Am J Clin Nutr (1970) 0.91
The paracentesis pendulum. Hepatology (1985) 0.91
Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices and ascites. Experimental design and preliminary results. Am J Surg (1969) 0.90
Unilateral edema and jaundice after portacaval anastomosis. Ann Intern Med (1972) 0.90
Erythromycin: clinical review. II. Therapeutic uses. N Y State J Med (1977) 0.90
Qualitative and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis. Gastroenterology (1970) 0.89
Predictors of outcome in massive upper gastrointestinal hemorrhage. J Clin Gastroenterol (1986) 0.89
Effects of lactulose and Lactobacillus acidophilus on the fecal flora. Am J Clin Nutr (1970) 0.89
Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis. Am J Dig Dis (1969) 0.89
Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec's cirrhosis. J Lab Clin Med (1970) 0.88
Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med (1976) 0.88
Severe diarrhea controlled by gamma globulin in a patient with agammaglobulinemia, amyloidosis, and thymoma. Ann Intern Med (1966) 0.88
Serum gastrin levels in primary hypogammaglobulinemia and pernicious anemia. Studies in adults. Ann Intern Med (1972) 0.87
Hepatic arterial escape from vasopressin-induced vasoconstriction: an angiographic investigation. Am J Roentgenol Radium Ther Nucl Med (1973) 0.87
Steroid treatment of alcoholic hepatitis. The yeas and the nays. Gastroenterology (1978) 0.86
Pyrogenicity of E. coli 055:b5 endotoxin by the USP rabbit test--a HIMA collaborative study. J Parenter Drug Assoc (1980) 0.86
Studies on the origin and significance of blood ammonia. II. The distribution of ammonia in whole blood, plasma and erythrocytes of man. Yale J Biol Med (1966) 0.86
Propranolol in portal hypertension: problems in paradise? Hepatology (1984) 0.85